Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Norbert Frickhofen"'
Autor:
Lorenz Thurner, Marita Ziepert, Christian Berdel, Christian Schmidt, Peter Borchmann, Dominic Kaddu-Mulindwa, Andreas Viardot, Mathias Witzens-Harig, Judith Dierlamm, Mathias Haenel, Bernd Metzner, Gerald Wulf, Eva Lengfelder, Ulrich B. Keller, Norbert Frickhofen, Maike Nickelsen, Tobias Gaska, Frank Griesinger, Rolf Mahlberg, Reinhard Marks, Ofer Shpilberg, Hans-Walter Lindemann, Martin Soekler, Ludwig Fischer von Weikersthal, Michael Kiehl, Eva Roemer, Martin Bentz, Beate Krammer-Steiner, Ralf Trappe, Peter de Nully Brown, Massimo Federico, Francesco Merli, Marianne Engelhard, Bertram Glass, Norbert Schmitz, Lorenz Truemper, Moritz Bewarder, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Andreas Rosenwald, Bettina Altmann, Heinz Schmidberger, Jochen Fleckenstein, Markus Loeffler, Viola Poeschel, Gerhard Held, on behalf of German Lymphoma Alliance (GLA)
Publikováno v:
HemaSphere, Vol 7, Iss 7, p e904 (2023)
UNFOLDER (Unfavorable Young Low-Risk Densification of R-Chemo Regimens) is an international phase-3 trial in patients 18–60 years with aggressive B-cell lymphoma and intermediate prognosis defined by age-adjusted International Prognostic Index (aaI
Externí odkaz:
https://doaj.org/article/1e8a36d90cfc4a6ab52a8d26ac285de3
Autor:
Gerhard Held, Lorenz Thurner, Viola Poeschel, German Ott, Christian Schmidt, Konstantinos Christofyllakis, Andreas Viardot, Peter Borchmann, Walburga Engel-Riedel, Norbert Frickhofen, Maike Nickelsen, Ofer Shpilberg, Mathias Witzens-Harig, Frank Griesinger, Beate Krammer-Steiner, Andreas Neubauer, Peter de Nully Brown, Massimo Federico, Bertram Glass, Norbert Schmitz, Gerald Wulf, Lorenz Truemper, Moritz Bewarder, Niels Murawski, Stephan Stilgenbauer, Andreas Rosenwald, Bettina Altmann, Marianne Engelhard, Heinz Schmidberger, Jochen Fleckenstein, Christian Berdel, Markus Loeffler, Marita Ziepert, on behalf of the German Lymphoma Alliance (GLA)
Publikováno v:
HemaSphere, Vol 7, Iss 7, p e917 (2023)
UNFOLDER (NCT00278408, EUDRACT 2005-005218-19) is a phase-3 trial in patients with aggressive B-cell lymphoma and intermediate prognosis, including primary mediastinal B-cell lymphoma (PMBCL). In a 2 × 2 factorial design, patients were randomized to
Externí odkaz:
https://doaj.org/article/f39990c175e24501836e410f27b615d4
Autor:
Carsten Hirt, Eva Hoster, Michael Unterhalt, Mathias Hänel, Gabriele Prange-Krex, Roswitha Forstpointner, Axel Florschütz, Ullrich Graeven, Norbert Frickhofen, Gerald Wulf, Eva Lengfelder, Christian Lerchenmüller, Rudolf Schlag, Judith Dierlamm, Ludwig Fischer von Weikersthal, Asima Ahmed, Hanns-Detlev Harich, Andreas Rosenwald, Wolfram Klapper, Martin Dreyling, Wolfgang Hiddemann, Michael Herold
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e600 (2021)
The German study groups, the German Low-Grade Lymphoma Study Group (GLSG) and Ostdeutsche Studiengruppe Hämatologie und Onkologie (OSHO), initiated in 2007 a double randomized trial to investigate efficacy and safety of rituximab maintenance versus
Externí odkaz:
https://doaj.org/article/7f58ca3174b5414e8506396f6d40af2b
Autor:
Sebastian Stasik, Jan M. Middeke, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/e2fa4b15317d40b6a7bb59bab5d3761c
Autor:
Jan-Niklas Eckardt, Sebastian Stasik, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W. Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiří Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Friedrich Stölzel, Frank Kroschinsky, Johannes Schetelig, Martin Bornhäuser, Christian Thiede, Jan Moritz Middeke
Publikováno v:
Cancers, Vol 13, Iss 9, p 2095 (2021)
Acute myeloid leukemia (AML) is characterized by recurrent genetic events. The BCL6 corepressor (BCOR) and its homolog, the BCL6 corepressor-like 1 (BCORL1), have been reported to be rare but recurrent mutations in AML. Previously, smaller studies ha
Externí odkaz:
https://doaj.org/article/5dd194885d13489f81c1c01b06f043ed
Autor:
Christian Straka, Peter Liebisch, Hans Salwender, Burkhard Hennemann, Bernd Metzner, Stefan Knop, Sigrid Adler-Reichel, Christian Gerecke, Hannes Wandt, Martin Bentz, Tim Hendrik Bruemmendorf, Marcus Hentrich, Michael Pfreundschuh, Hans-Heinrich Wolf, Orhan Sezer, Ralf Bargou, Wolfram Jung, Lorenz Trümper, Bernd Hertenstein, Else Heidemann, Helga Bernhard, Nicola Lang, Norbert Frickhofen, Holger Hebart, Ralf Schmidmaier, Andreas Sandermann, Tobias Dechow, Albrecht Reichle, Brigitte Schnabel, Kerstin Schäfer-Eckart, Christian Langer, Martin Gramatzki, Axel Hinke, Bertold Emmerich, Hermann Einsele
Publikováno v:
Haematologica, Vol 101, Iss 11 (2016)
Autologous transplantation is controversial for older patients with multiple myeloma. The role of age-adjusted high-dose melphalan and the impact of induction chemotherapy cycles is still unclear. A total of 434 patients aged 60–70 years were rando
Externí odkaz:
https://doaj.org/article/8484c26faddc436abed9f7a934ff997e
Autor:
Christian Straka, Kerstin Schaefer-Eckart, Bernd Hertenstein, Florian Bassermann, Hans Salwender, Christian Langer, Jan Krönke, Miriam Kull, Georgia Schilling, Aneta Schieferdecker, Monika Engelhardt, Stefan Knop, Julia Reusch, Wolf Roesler, Bernd Metzner, Holger Hebart, Albrecht Reichle, Matthias Grube, Norbert Frickhofen, Christian Gerecke, Stephan Fuhrmann, Wolfram Jung, Martin Gramatzki, Thomas Decker, Tobias Dechow, Jochen Greiner, Tim H. Brümmendorf, Juliana Ababei, Ivana von Metzler, Ralph Naumann, Elisabeth Fritz, Marcus Hentrich, Peter Bojko, Thomas Kubin, Christian Schmidt, Martin Kaufmann, Burkhard Schmidt, Axel Hinke, Hermann Einsele
Publikováno v:
Blood. 140:287-288
Autor:
Maja Rothenberg-Thurley, Jan-Niklas Eckardt, Richard Noppeney, Philipp A. Greif, Christoph Schliemann, Wolfgang E. Berdel, Norbert Frickhofen, Claudia D. Baldus, Gerhard Ehninger, Mathias Hänel, Christian Thiede, Dennis Görlich, Cristina Sauerland, Ralph Naumann, Martin Kaufmann, Christoph Röllig, Uwe Platzbecker, Utz Krug, Ulrich Kaiser, Hubert Serve, Alwin Kraemer, Markus Schaich, Friedrich Stölzel, Bernhard J. Woermann, Carsten Müller-Tidow, Tobias Herold, Andreas Neubauer, Andreas Burchert, Klaus H. Metzeler, Johannes Schetelig, Stefan W. Krause, Jan Moritz Middeke, Katja Sockel, Karsten Spiekermann, Kerstin Schaefer-Eckart, Sebastian Stasik, Wolfgang Hiddemann, Jan Braess, Andreas Hochhaus, Hermann Einsele, Tim H. Brümmendorf, Malte von Bonin, Michael Kramer, Martin Bornhäuser, Björn Steffen, Desiree Kunadt
Mutations of the isocitrate dehydrogenase-1 (IDH1) and IDH2 genes are among the most frequent alterations in acute myeloid leukemia (AML) and can be found in ∼20% of patients at diagnosis. Among 4930 patients (median age, 56 years; interquartile ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc862fde571105d6043fbbd83e873215
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85126099057
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85126099057
Autor:
Asima Ahmed, Judith Dierlamm, Wolfgang Hiddemann, Michael Unterhalt, Hanns-Detlev Harich, Gabriele Prange-Krex, Andreas Rosenwald, Ludwig Fischer von Weikersthal, Martin Dreyling, Rudolf Schlag, Michael Herold, Christian A. Lerchenmuller, M. Hänel, Ullrich Graeven, Roswitha Forstpointner, W. Klapper, Eva Hoster, Eva Lengfelder, A. Florschütz, Carsten Hirt, Gerald Wulf, Norbert Frickhofen
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e600 (2021)
HemaSphere
HemaSphere
The German study groups, the German Low-Grade Lymphoma Study Group (GLSG) and Ostdeutsche Studiengruppe Hamatologie und Onkologie (OSHO), initiated in 2007 a double randomized trial to investigate efficacy and safety of rituximab maintenance versus o
Autor:
Christoph Meisner, Martin Kaufmann, Ralf Bargou, Thomas Fischer, Orhan Sezer, Norbert Frickhofen, Marcus Hentrich, Hermann Einsele, Donald Bunjes, Hans-Heinrich Wolf, Stephan Mielke, Christian Schmidt, Ernst Holler, Christian Straka, Martin Gramatzki, Bernd Hertenstein, Peter Liebisch, Mathias Freund, Wolfram Jung, Bernd Metzner, Dietrich Peest, Florian Bassermann, Martin Kropff, Christian Langer, Georg Hess, Monika Engelhardt, M. Svaldi, Lothar Kanz, Stefan Knop, Helmut Ostermann, Holger Hebart, Georg Maschmeyer
Publikováno v:
Leukemia. 33:2710-2719
This phase 3 trial compared tandem autologous stem cell transplantation (autoSCT) versus autoSCT followed by reduced-intensity conditioning allogeneic stem cell transplantation (auto/alloSCT) in patients with newly diagnosed multiple myeloma (MM) wit